Literature DB >> 28644685

Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms.

Jennifer S Woo, Opal L Reddy, Matthew Koo, Yan Xiong, Faqian Li, Haodong Xu.   

Abstract

CONTEXT: - A vast majority of neoplasms arising from lung or pleura are initially diagnosed based on the histologic evaluation of small transbronchial, endobronchial, or needle core biopsies. Although most diagnoses can be determined by morphology alone, immunohistochemistry can be a valuable diagnostic tool in the workup of problematic cases.
OBJECTIVE: - To provide a practical approach in the interpretation and immunohistochemical selection of lung/pleura-based neoplasms obtained from small biopsy samples. DATA SOURCES: - A literature review of previously published articles and the personal experience of the authors were used in this review article.
CONCLUSION: - Immunohistochemistry is a useful diagnostic tool in the workup of small biopsies from the lung and pleura sampled by small biopsy techniques.

Entities:  

Mesh:

Year:  2017        PMID: 28644685     DOI: 10.5858/arpa.2016-0550-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

Review 1.  Update on Immunohistochemistry for the Diagnosis of Lung Cancer.

Authors:  Kentaro Inamura
Journal:  Cancers (Basel)       Date:  2018-03-14       Impact factor: 6.639

2.  A case of primary pulmonary leiomyosarcoma.

Authors:  Yoshiki Yata; Yuji Ito; Kimikazu Iwamoto; Akifumi Kumazawa; Tadashi Yosihara; Toshio Kato; Mitsushi Okazawa
Journal:  Respir Med Case Rep       Date:  2019-05-27

3.  Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  P Garrido; E Conde; J de Castro; J J Gómez-Román; E Felip; L Pijuan; D Isla; J Sanz; L Paz-Ares; F López-Ríos
Journal:  Clin Transl Oncol       Date:  2019-10-09       Impact factor: 3.405

4.  CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.

Authors:  Sara Bruschini; Simona di Martino; Maria Elena Pisanu; Luigi Fattore; Claudia De Vitis; Valentina Laquintana; Simonetta Buglioni; Eugenio Tabbì; Andrea Cerri; Paolo Visca; Gabriele Alessandrini; Francesco Facciolo; Christian Napoli; Marcella Trombetta; Antonio Santoro; Anna Crescenzi; Gennaro Ciliberto; Rita Mancini
Journal:  J Cell Physiol       Date:  2019-08-09       Impact factor: 6.384

5.  The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion.

Authors:  Monireh Halimi; Samad BeheshtiRouy; Davood Salehi; Seyed Ziaeddin Rasihashemi
Journal:  Iran J Pathol       Date:  2019-01-10

6.  Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.

Authors:  Talita Diniz Melo-Hanchuk; Mariana Bonjiorno Martins; Lucas Leite Cunha; Fernando Augusto Soares; Laura Sterian Ward; José Vassallo; Jörg Kobarg
Journal:  BMC Cancer       Date:  2020-01-06       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.